MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Weighting fibroblasts for future diagnostic prospect

    G. Prevot, E. Bezard, L. Cognet, B. Dehay, P. Bon (Bordeaux, France)

    Objective: To determine the dry mass of fibroblasts obtained from apparently healthy individuals and patients with brain disorders or cancer pathologies for future diagnosis prospect.…
  • 2019 International Congress

    Spiral Analysis Evaluates the Effects of Deep Brain Stimulation in Parkinson disease and Essential Tremor

    S. Radmard, S. Pullman (New York, NY, USA)

    Objective: To apply computerized spiral analysis to investigate upper limb kinematics and impact of deep brain stimulation (DBS) on motor dysfunction in Parkinson disease (PD) and…
  • 2019 International Congress

    Widespread distribution and abundant accumulation of alpha-synuclein oligomers in multiple system atrophy brain

    H. Sekiya, H. Kowa, H. Koga, M. Takata, W. Satake, N. Futamura, I. Funakawa, K. Jinnai, M. Kanagawa, K. Kobayashi, T. Toda (Kobe, Japan)

    Objective: To examine the distribution of alpha-synuclein (αSyn) oligomers as an early pathological change in multiple system atrophy (MSA) brains. Background: Although severe neuronal loss…
  • 2019 International Congress

    Maladaptive Nigrovagal Neuronal Plasticity Causes Ascending Alpha-Synucleinopathy in a Novel Environmental Toxin Based Rat Model of Parkinsonism

    T. Subramanian, K. Le, S. Hojjatinia, K. Venkiteswaran, M. Subramanian, L. Anselmi, C. Bove, R. Travagli (Hershey, PA, USA)

    Objective: Test the hypothesis that unilateral chemogenetic inhibition of the nigrovagal pathway in the subthreshold Paraquat (P) + dietary lectin (L) exposure rat model of…
  • 2019 International Congress

    Alpha-synuclein interacts with BAF complex in nucleus

    N. Sugeno, T. Hasegawa, J. Kobayashi, S. Yoshida, M. Ezura, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)

    Objective: This study aims to uncover the prospective partner of αS in nucleus. Background: In neuronal cells, large part of alpha-synuclein (αS) localize at presynaptic…
  • 2019 International Congress

    Central Insulin Resistance Index is Independent of Peripheral Insulin Resistance in Parkinson’s disease

    M. Tagliati, E. Hogg, T. Wu, K. Makwana, H. Maghzi, A. Garland, E. Tan, C. Riera (Los Angeles, CA, USA)

    Objective: To correlate brain insulin signalling with peripheral insulin resistance using neuronally derived blood exosomes in patients with Parkinson's Disease (PD) Background: Insulin signaling abnormalities may…
  • 2019 International Congress

    Co-administration of levodopa and zonisamide reduces the serotonin transporter expression in a rat model of Parkinson’s disease

    R. Tohge, S. Kaneko, S. Morise, M. Oki, M. Nakamura, N. Takenouchi, H. Kusaka (Hirakata, Japan)

    Objective: To investigate the change of striatal serotonergic system according to the administration of levodopa and zonisamide (ZNS) on the striatal serotonergic system, we analyzed the…
  • 2019 International Congress

    The role of lipid metabolism in mouse models of Parkinson’s disease

    M. Trabjerg, D. Andersen, P. Huntjens, K. Mørk, M. Skjønnemand, M. Oklinski, A. Mørkholt, I. Huijbers, C. Pritchard, L. Kroese, J. Nieland (Aalborg, Denmark)

    Objective: To investigate the role of lipid metabolism and the effect of blocking carnitine palmitoyl-transferase 1 (CPT1) in toxic and genetically mouse models of Parkinson’s…
  • 2019 International Congress

    Experimental model of developing of Parkinson’s disease

    M. Tukhtamishev, F. Akhmedova (Tashkent, Uzbekistan)

    Objective: Analyzing the reserpine model of Parkinsonian syndrome Background: There are several experimental models of Parkinson's disease: reserpine, methamphetamine, 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - substances that…
  • 2019 International Congress

    Motor compensation in Parkinson’s disease: a multimodal neuroimaging study

    N. Villain, N. Pyatigorskaya, S. Lehericy, R. Vallabregue, S. Fernandez-Vidal, MO. Habert, G. Mangone, JC. Corvol, M. Vidailhet, D. Grabli (Paris, France)

    Objective: To study motor compensation mechanisms in Parkinson's disease. Background: Whereas akinesia in Parkinson's disease (PD) is linked to dopaminergic neurons death and striatal dopamine depletion,…
  • « Previous Page
  • 1
  • …
  • 1357
  • 1358
  • 1359
  • 1360
  • 1361
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley